REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, 2829-516, Portugal.
J Mol Recognit. 2013 Dec;26(12):662-71. doi: 10.1002/jmr.2309.
This paper presents a sustainable strategy for improving the capture of antibodies by affinity chromatography. A novel biomimetic ligand (4-((4-chloro-6-(3-hydroxyphenoxy)-1,3,5-triazin-2-yl)oxy)naphthalen-1-ol) (TPN-BM) was synthesized using a greener and simple protocol to overcome solubility limitations associated with ligand 22/8, known as artificial protein A. Furthermore, its subsequent immobilization on chitosan-based monoliths induced by plasma surface activation allowed the design of a fast and efficient chromatographic platform for immunoglobulin G (IgG) purification. The TPN-BM functionalized monoliths exhibited high-binding capacity (160 ± 10 mg IgG per gram of support), and a selective capture of monoclonal antibodies directly from mammalian crude extracts in 85 ± 5% yield and 98% of purity. The synthesis of ligand TPN-BM and the routes followed for monoliths preparation and functionalization were inspired in the green chemistry principles allowing the reduction of processing time, solvents and purification steps involved, turning the integrated system attractive from an economical and chemical point of view.
本文提出了一种可持续的策略,用于提高亲和层析对抗体的捕获能力。采用一种更绿色、更简单的方案合成了一种新型仿生配体(4-((4-氯-6-(3-羟基苯氧基)-1,3,5-三嗪-2-基)氧基)萘-1-醇)(TPN-BM),以克服与配体 22/8 相关的溶解度限制,配体 22/8 被称为人工蛋白 A。此外,通过等离子体表面活化将其随后固定在壳聚糖基整体柱上,设计了一种用于免疫球蛋白 G(IgG)纯化的快速有效的色谱平台。TPN-BM 功能化整体柱具有高结合容量(每克载体 160±10mg IgG),可直接从哺乳动物粗提物中以 85±5%的收率和 98%的纯度选择性捕获单克隆抗体。配体 TPN-BM 的合成以及整体柱制备和功能化所采用的路线均受到绿色化学原则的启发,可减少处理时间、溶剂和纯化步骤,从经济和化学角度来看,集成系统具有吸引力。